Cardiac sarcoidosis is a rare complication of pulmonary sarcoidosis, causing granulomatous inflammation the myocardium, ultimately resulting in infiltrative cardiomyopathy. Through fibrotic inflammation, cardiac predisposes patients to multiple complications, such as conduction abnormalities, ventricular arrhythmias, heart failure, and sudden death. Due adverse prognosis abnormalities these pat...

Dsg: desmoglein H&E: hematoxylin-eosin IL: interleukin PH: pemphigus herpetiformis INTRODUCTION Pemphigus herpetiformis (PH) is a rare variant of pemphigus and accounts for approximately 7% of cases. PH combines the clinical features of dermatitis herpetiformis with the histologic features of pemphigus. Clinically, the plaques are herpetiform or even annular. PH follows a more benign course wit...

BACKGROUND Sarcoidosis is a systemic granulomatous disease of unknown cause that affects the lungs in over 90% of cases. Breath analysis by electronic nose technology provides exhaled molecular profiles that have potential in the diagnosis of several respiratory diseases. OBJECTIVES We hypothesized that exhaled molecular profiling may distinguish well-characterized patients with sarcoidosis f...

Background/Aim: Sarcoidosis is a multisystem inflammatory disease characterized by the infiltration of various organs. Due to lack widely-accepted biomarker, researchers have explored alternative and previously unexplored parameters in sarcoidosis. This study aimed investigate utility markers, including systemic immune-inflammation index (SII) pan-immune-inflammation value (PIV), patients with ...

Sarcoidosis predominantly affects the lungs, intrathoracic lymph nodes, and eyes; it less frequently affects the musculoskeletal system. We herein report a case of paraneoplastic sarcoidosis in a patient presenting with multiple myeloma. The patient developed ocular sarcoidosis and showed an increased 18F-fluorodeoxyglucose uptake in the mediastinal lymph nodes and vertebral column. A lymph nod...

Sarcoidosis is a multisystem granulomatous disease that can affect any organ in the body, but most commonly the lung. Any part of the thorax may be affected by sarcoidosis, including the lung parenchyma, airways, and mediastinal and hilar lymph nodes. When the parenchyma is involved, sarcoidosis has a predilection for the bronchovascular bundles and subpleural locations. On occasion, the presen...

BACKGROUND Sarcoidosis is a multisystemic disease of unknown etiology characterized by a disproportionate Th1 granulomatous immune response in the organs involved. Plasmatic hypergammaglobulinemia and B cell accumulation in granulomatous lesions suggest the possible role of humoral immune responses in the pathogenesis of sarcoidosis. The purpose of this study is to describe B cell peripheral co...

Sarcoidosis is a multiorgan granulomatous disease in which the skin is one of the frequently involved target organs. Cutaneous involvement occurs in a third of patients with sarcoidosis and has protean manifestations. More than a century has passed since the initial description of sarcoidosis, but its cause continues to be an enigma. Recent studies have introduced several new insights into the ...

sparing in acute sarcoidosis: Results of a double, blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 17:60, 2000 67. Fazzi P: Pharmacotherapeutic management of pulmonary sarcoidosis. Am J Respir Med 2:311, 2003 68. Topalov DT, Videnovic JV, Radosavljenic TR: The long term use of methotrexate in patients with chronic disseminated sarcoidosis. Chest 118:245, 2000 69. Baugmann RP, Lynch J...

INTRODUCTION Sarcoidosis is a systemic granulomatous disease of unknown cause. The management of sarcoidosis remains problematic. Systemic and topical corticosteroids are the mainstay of therapy but may cause unacceptable side effects. Biologic therapies, such as infliximab, have recently been proposed as another treatment option for cutaneous sarcoidosis. CASE REPORT The authors describe thr...